MktsMarkets

Pliant Therapeutics, Inc.
NASDAQ: PLRXKey statistics
PLRX News
Stories mentioning PLRX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | |||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Operating Expenses | ||||||||
| Research & Development | 13,584 | 15,585 | 17,938 | 32,198 | 43,436 | 38,793 | 47,754 | 45,617 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 21,772 | 23,577 | 28,269 | 45,592 | 58,935 | 53,320 | 62,014 | 60,639 |
| Operating Income (Loss) | (21,772) | (23,577) | (28,269) | (45,592) | (58,935) | (53,320) | (62,014) | (60,639) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | (20,040) | (23,577) | (26,301) | (43,300) | (56,166) | (49,732) | (57,763) | (55,854) |
| Earnings Per Share (Basic) | (0.32) | (0.38) | (0.43) | (0.71) | (0.92) | (0.82) | (0.95) | (0.92) |
| Earnings Per Share (Diluted) | (0.32) | (0.38) | (0.43) | (0.71) | (0.92) | (0.82) | (0.95) | (0.92) |
| Weighted Average Shares Outstanding (Basic) | 61,803 | 61,367 | 61,406 | 61,386 | 61,223 | 60,539 | 60,731 | 60,383 |
| Weighted Average Shares Outstanding (Diluted) | 61,803 | 61,367 | 61,406 | 61,386 | 61,223 | 60,539 | 60,731 | 60,383 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PLRX
Pliant Therapeutics, Inc. (NASDAQ: PLRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol PLRX. It last traded at $0.7000 (Nov 13, 2026, 4:00 PM ET), down 5.8% on the day. That gives Pliant Therapeutics a market capitalisation of $43.2M.
Over the past 52 weeks PLRX has traded between $0.6900 and $1.80.
For the quarter ended Mar 31, 2026 it reported a net loss of $20.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$20.0M |
| Dec 31, 2025 | — | -$23.6M |
| Sep 30, 2025 | — | -$26.3M |
| Jun 30, 2025 | — | -$43.3M |
From Pliant Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…